Answers are grounded in this paper and cite their sources.
Glucagonoma is a well-differentiated slowly proliferating pancreatic neuroendocrine tumor, characterized by variable manifestations related to glucagon excess. Glucagonoma syndrome is a rare neuroendocrine tumor-related syndrome, characterized by a frequent and early cutaneous manifestation, the necrolytic migratory erythema, along with variable systemic involvement. We present a case of a 51-year-old female diagnosed with glucagonoma, highlighting the clinical features, diagnostic approach, and management strategies. Early recognition of the necrolytic migratory erythema and multidisciplinary care of the syndrome are crucial for optimizing outcomes in affected patients.
No takes yet. Share an insight, caveat, or question.
Zamponi et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: